Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty

Journal of Nuclear Medicine

Volumn 41, Issue 7, 2000, Pages 1203-1208

  Müller Suur, Roland ^a   Tidgren, Bo ^a   Fehrm, Anders ^a   Lundberg, Hans Jerker ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

99mtc mercaptoacetyltriglycine; Hypertension; Plasma clearance; Renal angioplasty; Renal artery stenosis

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MERTIATIDE TC 99M;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMA CLEARANCE; PRIORITY JOURNAL; RENOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MIDDLE AGED; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; RENAL ARTERY OBSTRUCTION; TECHNETIUM TC 99M MERTIATIDE;

EID: 18244429388     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wenting GJ, Tan-Tjiong HL, Derkx FHM, De Bruyn JH, Man Int Veld AJ, Schalekamp MADH. Split renal function after captopril in unilateral renal artery stenosis. Br Med J. 1984;288:886-890.
2. Jonker GJ, Visscher CA, Zeeuw D, et al. Changes in renal function induced by ACE inhibition in the conscious two kidney, one clip Goldblatt hypertensive dog. Nephron. 1992;60:226-231.
3. Dubovsky EV, Russel CD. Diagnosis of renovascular hypertension after renal transplantation. Am J Hypertens. 1991;4:724S-730S.
4. Einstein/Cornell collaborative hypertension group. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. J Nucl Med. 1998;39:522-528.
5. Nielsen CB, Pedersen EB. Effects of caplopril on renal function in healthy uninephrectomized subjects and in healthy control subjects. J Intern Med. 1994;235:359-365.
6. Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography detecting renovascular hypertension. J Nucl Med. 1996;37:1876-1882.
7. Müller FB, Sealey JE, Case DB, et al. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med. 1986;80:633-644.
8. Müller-Suur R, Magnusson G, Bois-Svensson I, Jansson B. Estimation of technetium 99m mercaptoacetyltrigtycine plasma clearance by use of one single plasma sample. Eur J Nucl Med. 1991;18:28-31.
9. Taylor A, Eshima D. Renal artery stenosis and ischemia: effect on renal blood flow and extraction fraction. Hypertension. 1994;23:96-103.
10. Visscher CA, de Zeeuw D, de Jong PE, et al. Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension. J Nucl Med. 1996;27:482-488.
11. Müller-Suur R. Radiopharmaceuticals, their intrarenal handling and localisation. In: Murray ICP, Ell J, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. Vol 1. Edinburgh, Scotland: Churchill Livingstone; 1998:195-219.
12. Prigent A. The diagnosis of renovascular hypertension: the role of captopril renal scintigraphy and related issues. Eur J Nucl Med. 1993;20:625-644.
13. Blaufox MD, Middleton ML, Bongiovanni J, Davis BR. Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med. 1996;37:171-177.
14. Wenting GJ, Derkx FHM, Tan-Tjiong LH, van Seyen AJ, Man Int Veld A, Schalekamp MADH. Risks of angiotensin converting enzyme inhibition in renal artery stenosis. Kidney Int. 1987;31(suppl 29):S180-S183.
15. 99Tc-m-MAG-3 renal clearance in the long term management of patients with spinal cord injury [abstract]. Nucl Med Commun. 1998;19:494.